Affiliation:
1. Department of Neurodegeneration Diagnostics, Medical University of Białystok, 15-089 Białystok, Poland
2. Department of Biochemical Diagnostics, University Hospital in Białystok, 15-269 Białystok, Poland
3. Dementia Disorders Centre, Medical University of Wroclaw, 50-425 Ścinawa, Poland
Abstract
A presynaptic protein called α-synuclein plays a crucial role in synaptic function and neurotransmitter release. However, its misfolding and aggregation have been implicated in a variety of neurodegenerative diseases, particularly Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Emerging evidence suggests that α-synuclein interacts with various cellular pathways, including mitochondrial dysfunction, oxidative stress, and neuroinflammation, which contributes to neuronal cell death. Moreover, α-synuclein has been involved in the propagation of neurodegenerative processes through prion-like mechanisms, where misfolded proteins induce similar conformational changes in neighboring neurons. Understanding the multifaced roles of α-synuclein in neurodegeneration not only aids in acquiring more knowledge about the pathophysiology of these diseases but also highlights potential biomarkers and therapeutic targets for intervention in alpha-synucleinopathies. In this review, we provide a summary of the mechanisms by which α-synuclein contributes to neurodegenerative processes, focusing on its misfolding, oligomerization, and the formation of insoluble fibrils that form characteristic Lewy bodies. Furthermore, we compare the potential value of α-synuclein species in diagnosing and differentiating selected neurodegenerative diseases.
Funder
Medical University of Białystok
Reference129 articles.
1. Advancing cell therapy for neurodegenerative diseases;Temple;Cell Stem Cell,2023
2. Inflammation in CNS neurodegenerative diseases;Stephenson;Immunology,2018
3. Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.
4. Protein aggregation and neurodegenerative diseases: From theory to therapy;Kumar;Eur. J. Med. Chem.,2016
5. Biology and genetics of prions causing neurodegeneration;Prusiner;Annu. Rev. Genet.,2013